Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 01, 2024 09:00 ET | Source: Parexel International LLC

Parexel Appoints Susan R. Salka to Board of Directors

DURHAM, N.C., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
January 10, 2024 08:55 ET | Source: Parexel International LLC

Parexel and Japanese Foundation for Cancer Research Announce Strategic Alliance

DURHAM, N.C. and TOKYO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development...
November 17, 2023 07:30 ET | Source: Parexel International LLC

Parexel Named “Best Contract Research Organization” at 19th Annual Scrip Awards

DURHAM, N.C., Nov. 17, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
November 08, 2023 08:55 ET | Source: Parexel International LLC

Parexel Named 2023 Healthcare Businesswomen’s Association ACE Award Honoree

DURHAM, N.C., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
October 12, 2023 08:55 ET | Source: Parexel International LLC

Global Investigative Sites Recognize Parexel with the 2023 Society for Clinical Research Sites Eagle Award

DURHAM, N.C., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
September 20, 2023 08:55 ET | Source: Parexel International LLC

Parexel’s Amy McKee, M.D. Named to 2023 PharmaVoice 100

DURHAM, N.C., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
September 19, 2023 08:55 ET | Source: Parexel International LLC

Parexel Appoints Gwyn Bebb, BM, BCh., Ph.D., to Lead Oncology Clinical Development

DURHAM, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
August 15, 2023 07:00 ET | Source: Parexel International LLC

Parexel and Partex Announce Innovative Alliance Leveraging Artificial Intelligence and Big Data to Accelerate Drug Discovery and Development

Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets ...
June 23, 2023 08:49 ET | Source: Parexel International LLC

Parexel Announces Updates to Board of Directors

Goldman Sachs’ Partner, Global co-Head of Private Equity Michael Bruun joins as new Director, succeeding current Goldman Sachs Board member Jo Natauri who is retiring from the firm at the end of the...
May 31, 2023 09:00 ET | Source: Parexel International LLC

Parexel Rated “Top CRO to Work With” in 2023 WCG CenterWatch Global Site Relationship Benchmark Survey for Second Straight Time

DURHAM, N.C., May 31, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...